|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | |
| A61K 9/51 | |||
| A61K 31/551 |
| (11) | Number of the document | 1827374 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05851701.2 |
| Date of filing the European patent application | 2005-11-16 | |
| (97) | Date of publication of the European application | 2007-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/041470 |
| Date | 2005-11-16 |
| (87) | Number | WO 2006/055603 |
| Date | 2006-05-26 |
| (30) | Number | Date | Country code |
| 628748 P | 2004-11-16 | US |
| (72) |
LIVERSIDGE, Gary, US
JENKINS, Scott, US
LIVERSIDGE, Elaine, US
|
| (73) |
Alkermes Pharma Ireland Limited,
Connaught House 1 Burlington Road, Dublin 4,
IE
|
| (54) | INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS |
| INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS |